Table 1 Risk factors for post-transplant diabetes development
Non-modifiable | Potentially modifiable | Modifiable |
|---|---|---|
Ethnicity (non-Caucasian) | Infections | Immunosuppressive Therapy |
Age >40 years-old | • HCV | • Tacrolimus |
Recipient's gender (M) | • CMV | • Cyclosporine |
Donor's gender (M) | IGT (pre-transplantation) | • Corticosteroid |
Family history of DM | • Sirolimus | |
HLA | Obesity | |
HLA (mismatches) | MS components | |
Cadaver-donor | ||
History of acute rejection |